Developing a community-supported risk reduction intervention for syringe exchange registrants and their drug-free family or friends: a pilot study

References

• Blanco C, Wiley T, Lloyd JJ, Lopez MF, Volkow ND. America's opioid crisis: the need for an integrated public health approach. Transl Psychiatry. 2020;10(1):167. doi:10.1038/s41398-020-0847-1.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104(9):1441–6. doi:10.1111/j.1360-0443.2008.02465.x.
   PubMed Web of Science ®Google Scholar
• Bramson H, Des Jarlais DC, Arasteh K, Nugent A, Guardino V, Feelemyer J, Hodel D. State laws, syringe exchange, and HIV among persons who inject drugs in the United States: history and effectiveness. J Public Health Policy. 2015;36(2):212–30. doi:10.1057/jphp.2014.54.
   PubMed Web of Science ®Google Scholar
• Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235–48. doi:10.1093/ije/dyt243.
   PubMed Web of Science ®Google Scholar
• Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105(5):844–59. doi:10.1111/j.1360-0443.2009.02888.x.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Braine N, Yi H, Turner C. Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. AIDS Educ Prev. 2007;19(2):111–23. doi:10.1521/aeap.2007.19.2.111.
   PubMed Web of Science ®Google Scholar
• Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;33(2):199–205. doi:10.1097/00126334-200306010-00014.
   PubMed Web of Science ®Google Scholar
• Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503–8. doi:10.1001/archpsyc.58.5.503.
   PubMed Web of Science ®Google Scholar
• Buchanan AS, Latkin CA. Drug use in the social networks of heroin and cocaine users before and after drug cessation. Drug Alcohol Depend. 2008;96(3):286–9. doi:10.1016/j.drugalcdep.2008.03.008.
   PubMed Web of Science ®Google Scholar
• De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9. doi:10.1111/j.1360-0443.2007.01936.x.
   PubMed Web of Science ®Google Scholar
• Tobin KE, Hua W, Costenbader EC, Latkin CA. The association between change in social network characteristics and non-fatal overdose: results from the SHIELD study in Baltimore, MD, USA. Drug Alcohol Depend. 2007;87(1):63–8. doi:10.1016/j.drugalcdep.2006.08.002.
   PubMed Web of Science ®Google Scholar
• Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, Knowlton A. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995;38(1):1–9. doi:10.1016/0376-8716(94)01082-V.
   PubMed Web of Science ®Google Scholar
• Kidorf M, Latkin C, Brooner RK. Presence of drug-free family and friends in the personal social networks of people receiving treatment for opioid use disorder. J Subst Abuse Treat. 2016;70:87–92. doi:10.1016/j.jsat.2016.08.013.
   PubMed Web of Science ®Google Scholar
• Klostermann K, O’Farrell TJ. Treating substance abuse: partner and family approaches. Soc Work Public Health. 2013;28(3-4):234–47. doi:10.1080/19371918.2013.759014.
   PubMed Web of Science ®Google Scholar
• Kumpfer KL, DeMarsh JP, Child W. Strengthening Families Program: Children’s Skills Training Curriculum Manual, Parent Training Manual, Children’s Skills Training Manual, and Family Skills Training Manual. Salt Lake City, UT: University of Utah, Social Research Institute, Graduate School of Social Work; 1989.
   Google Scholar
• Bohnert AS, German D, Knowlton AR, Latkin CA. Friendship networks of inner-city adults: a latent class analysis and multi-level regression of supporter types and the association of supporter latent class membership with supporter and recipient drug use. Drug Alcohol Depend. 2010;107(2-3):134–40. doi:10.1016/j.drugalcdep.2009.09.012.
   PubMed Web of Science ®Google Scholar
• Meyers RJ, Miller WR, Smith JE, Tonigan JS. A randomized trial of two methods for engaging treatment-refusing drug users through concerned significant others. J Consult Clin Psychol. 2002;70(5):1182–5. doi:10.1037/0022-006X.70.5.1182.
   PubMed Web of Science ®Google Scholar
• Kidorf M, King VL, Gandotra N, Kolodner K, Brooner RK. Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes. Drug Alcohol Depend. 2012;124(1-2):162–6. doi:10.1016/j.drugalcdep.2011.12.008.
   PubMed Web of Science ®Google Scholar
• Kidorf M, King VL, Neufeld K, Peirce J, Kolodner K, Brooner RK. Improving substance abuse treatment enrollment in community syringe exchangers. Addiction. 2009;104(5):786–95. doi:10.1111/j.1360-0443.2009.02560.x.
   PubMed Web of Science ®Google Scholar
• Kidorf M, Brooner RK, Peirce J, Gandotra J, Leoutsakos JM. Mobilizing community support in people receiving opioid-agonist treatment: a group approach. J Subst Abuse Treat. 2018;93:1–6. doi:10.1016/j.jsat.2018.07.004.
   PubMed Web of Science ®Google Scholar
• Kidorf M, King VL, Neufeld K, Stoller KB, Peirce J, Brooner RK. Involving significant others in the care of opioid-dependent patients receiving methadone. J Subst Abuse Treat. 2005;29(1):19–27. doi:10.1016/j.jsat.2005.03.006.
   PubMed Web of Science ®Google Scholar
• Metzger D, Woody GE, Navaline H, McLellan AT, Meyers K, Boney T, Mulvaney F, Williams J, Dyanick ST, Johnson A, et al. The Risk Assessment Battery (RAB): validity and reliability. In Sixth Annual Meeting of National Cooperative Vaccine Development Group for AIDS. Alexandria, VA, 1993; October 30–November 4, 1993.
   Google Scholar
• Kidorf M, Disney ER, King VL, Neufeld K, Beilenson PL, Brooner RK. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend. 2004;74(2):115–22. doi:10.1016/j.drugalcdep.2003.11.014.
   PubMed Web of Science ®Google Scholar
• Tobin KE, Kuramoto SJ, Davey-Rothwell MA, Latkin CA. The STEP into action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction. 2011;106(2):366–75. doi:10.1111/j.1360-0443.2010.03146.x.
   PubMed Web of Science ®Google Scholar
• Campbell BK, Manuel JK, Manser ST, Peavy KM, Stelmokas J, McCarty D, Guydish JR. Assessing fidelity of treatment delivery in group and individual 12-step facilitation. J Subst Abuse Treat. 2013;44(2):169–76. doi:10.1016/j.jsat.2012.07.003.
   PubMed Web of Science ®Google Scholar
• Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, et al. How we design feasibility studies. Am J Prev Med. 2009;36(5):452–7. doi:10.1016/j.amepre.2009.02.002.
   PubMed Web of Science ®Google Scholar
• Peirce, JM, Brooner, RK, King, VL, Kidorf, M. Effect of traumatic event reexposure and PTSD on substance use disorder treatment response. Drug Alcohl Depend. 2016;158(1):126–31. doi:10.1016/j.drugalcdep.2015.11.006
   PubMedGoogle Scholar
• Peirce, JM, Brooner, RK, Kolodner, KK, Schacht, RL., Kidorf, MS. Prospective efects of traumtaic event reexposure and post-traumatic stress disorder in syringe exchange participants. Addiction. 2013;108(1):146–53. doi:10.1111/j.1360-0443.2012.04003.x.
   PubMed Web of Science ®Google Scholar
• Suomi A, Evans L, Rodgers B, Taplin S, Cowlishaw S. Couple and family therapies for post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2019;12(12):CD011257. doi:10.1002/14651858.CD011257.pub2.
   PubMedGoogle Scholar
• Magill M, Martino S, Wampold BE. The process of skills training: an evidence-based analysis of addiction therapies. J Subst Abuse Treat. 2020;116:108063. doi:10.1016/j.jsat2020.108063.
   PubMed Web of Science ®Google Scholar
• Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP. Predictors of methadone treatment retention from a multi-site study: a survival analysis. Drug Alcohol Depend. 2011;117(2-3):170–5. doi:10.1016/j.drugalcdep.2011.01.008.
   PubMed Web of Science ®Google Scholar
• Litt MD, Kadden RM, Kabela-Cormier E, Petry N. Changing network support for drinking: initial findings from the network support project. J Consult Clin Psychol. 2007;75(4):542–55. doi:10.1037/0022-006X.75.4.542.
   PubMed Web of Science ®Google Scholar
• Kidorf M, King VL, Peirce J, Pierce J, Kolodner K, Brooner RK. Benefits of concurrent syringe exchange and substance abuse treatment participation. J Subst Abuse Treat. 2011;40(3):265–71. doi:10.1016/j.jsat.2010.11.011.
   PubMed Web of Science ®Google Scholar
• Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):1454–62. doi:10.1111/j.1360-0443.2007.01912.x.
   PubMed Web of Science ®Google Scholar
• Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;(8):CD004145. doi:10.1002/14651858.CD004145.pub4.
   PubMed Web of Science ®Google Scholar